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Purpose: Evidence suggests that technological innovations and reimbursement 
schemes of the National Health Insurance Service may have impacted the manage-
ment of coronary artery disease. Thus, we investigated changes in the practice pat-
terns of coronary revascularization. Materials and Methods: Revascularization 
and in-hospital mortality among Koreans ≥20 years old were identified from medical 
claims filed between 2006 and 2010. The age- and sex-standardized procedure rate 
per 100000 person-years was calculated directly from the distribution of the 2008 Ko-
rean population. Results: The coronary revascularization rate increased from 116.1 
(95% confidence interval, 114.9‒117.2) in 2006 to 131.0 (129.9‒132.1) in 2010. Com-
pared to the rate ratios in 2006, the rate ratios for percutaneous coronary intervention 
(PCI) and coronary artery bypass graft (CABG) surgery in 2010 were 1.16 (1.15‒1.17) 
and 0.80 (0.76‒0.84), respectively. Among patients who received PCI, the percent-
age with drug-eluting stents increased from 89.1% in 2006 to 93.0% in 2010. In-hospi-
tal mortality rates from PCI significantly increased during the study period (p=0.03), 
whereas those from CABG significantly decreased (p=0.01). The in-hospital mortal-
ity rates for PCI and CABG were higher in elderly and female patients and at the 
lowest-volume hospitals. Conclusion: The annual volume of coronary revascular-
ization continuously increased between 2006 and 2010 in Korea, although this trend 
differed according to procedure type. A high percentage of drug-eluting stent proce-
dures and a high rate of in-hospital mortality at low-volume hospitals were noted.
Key Words:   Myocardial revascularization, percutaneous coronary intervention, 
insurance, reimbursement
INTRODUCTION
Most percutaneous coronary intervention (PCI) procedures are electively performed 
in patients with stable coronary artery disease.1 However, recent advancements in 
catheter-based technology, radiographic imaging, and stent composition and de-
ployment have allowed PCI to be performed in patients with diffuse lesions, multi-
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during hospitalization for coronary revascularization. PCI 
procedures were classified as BMS or DES based on the 
medical device codes in the HIRA system; the types of DES 
were further classified as first, second, or third generation.17 
PCI procedures that did not include BMS or DES were des-
ignated as angioplasties. Hospitals were divided into tertiles 
based on the annual number of PCI or coronary artery by-
pass graft (CABG) procedures each year. 
The proportional differences in sex, age, stent type, and 
in-hospital mortality from 2006 to 2010 were investigated 
using the chi-square test. The age- and sex-standardized pro-
cedure rate per 100000 person-years was directly calculated 
from the distribution of the 2008 Korean population. The 
rate ratios (RRs) of coronary revascularization and the 95% 
confidence intervals were estimated with the Poisson re-
gression model after adjusting for age and gender, and a 
trend test in which ordinal scores were assigned to calendar 
years was also performed. In the Poisson regression model, 
the specific number of procedures according to each calen-
dar year, age, and gender was used as a dependent variable, 
and the size of the population at risk (mid-year population 
in each year) was used as an offset term. An event of coro-
nary revascularization was considered a unit of analysis.
The risk of in-hospital mortality was estimated with a gen-
eralized linear mixed-effects model for binomial data using a 
logit link function; stratified analyses by age, gender, and pro-
cedure volume in each hospital were performed. A linear trend 
test was also performed after including ordinal scores for 
each calendar year in the generalized linear mixed-effects 
model. Due to the potential effects of annual procedure vol-
umes, we included tertiles of procedure volume as a random 
effect and sex, age group, and year of procedure as indepen-
dent variables in the generalized linear mixed-effects model. 
To explore the pattern of repeated coronary revasculariza-
tion after PCI, we constructed a procedure cohort consisting 
of patients who received PCI from 2007 to 2009 and did not 
have prior revascularization within the preceding12 months. 
The procedure cohort was followed for 12 months. 
All statistical analyses were performed with SAS version 
9.1.3 (SAS Institute Inc., Cary, NC, USA). 
RESULTS
Utilization of coronary revascularization
Among 210914 patients, 247325 coronary revascularization 
procedures were reported between 2006 and 2010. Table 1 
vessel disease, and left-main disease.2-8 Bare-metal stents 
(BMS) and drug-eluting stents (DES) improve outcomes 
from angioplasty by providing mechanical support.
Compared to BMS, DES release immunosuppressive and 
anti-proliferative drugs and consequently prevent neointimal 
hyperplasia, which is a leading cause of restenosis in pa-
tients with BMS.9,10
Several clinical studies have shown that, compared with 
the previous era when BMS were used, the use of DES has 
had relatively lower rates of restenosis, relieving concerns 
about technical problems.11,12 However, since 2006, several 
studies have reported that the use of PCI as an initial treat-
ment for stable coronary artery disease does not reduce the 
risk of major cardiovascular events.13 Furthermore, these re-
ports show that the use of DES increases the risk of stent 
thrombosis.14,15 Consequently, there have been changes in 
the management of coronary disease in Western countries.16
In the Republic of Korea (ROK), all Koreans are required 
to participate in the National Health Insurance (NHI) pro-
gram. Thus, in addition to differences in the clinical charac-
teristics of coronary artery disease in different individuals, 
the practice patterns for coronary revascularization in the 
ROK might differ from those in other countries due to reim-
bursement policies. However, there have been no studies on 
this issue. Therefore, in this study, we investigated changes 
in the practice patterns of coronary revascularization and the 
risk of in-hospital mortality after coronary revascularization. 
MATERIALS AND METHODS
Medical claims data reported to the Health Insurance Re-
view and Assessment Service (HIRA) between 2006 and 
2010 were used to identify cases of coronary revasculariza-
tion. Due to the NHI program, all clinics and hospitals must 
submit medical utilization data to HIRA, including disease 
codes [International Classification of Diseases, 10th revision 
(ICD10)], diagnostic and treatment procedures, drug pre-
scriptions, outcomes of hospitalization, and medical costs. 
We identified cases of coronary revascularization among 
patients admitted with cardiovascular diseases (I21‒I25) 
who were ≥20 years old. Thus, all patients who received 
elective, urgent, and emergency coronary revascularization 
procedures were included. However, due to the lack clinical 
data for patients, we could not provide further differentiation 
in the analysis. 
In-hospital mortality was defined as deaths from all causes 
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(≥65 years old) patients who received PCI or CABG in-
creased over the 5-year period. The number of hospitals that 
provided PCI and CABG increased by 23.5% and 13.0%, 
respectively. 
Age- and sex-adjusted coronary revascularization rate 
The age- and sex-standardized rate of PCI per 100000 per-
son-years increased during the 5-year study period. The rate 
of PCI increased from 106.5 in 2006 to 123.4 in 2010. How-
ever, the rate of CABG decreased from 9.5 in 2006 to 7.6 in 
2010 (Table 2). The rates for PCI and CABG were highest 
among men and elderly patients (55‒74 years old). 
shows the annual number of coronary revascularization pro-
cedures from 2006 to 2010 by sex, age, and type of revascu-
larization. The number of PCI procedures increased by 35%, 
whereas the number of CABG procedures decreased by 
6.5%. The increase in PCI was observed in each age and sex 
group. The proportion of patients who received DES contin-
uously increased from 89.1% in 2006 to 93.0% in 2010 (Ta-
ble 1). Fig. 1 shows the quarterly distribution of PCI accord-
ing to the type of stent. 
A reduced number of CABG procedures was observed in 
both genders and in each age strata, with the exception of 
the ≥75-year-old group. The percentages of male and elderly 
Table 1. Annual Number of Coronary Revascularizations According to Sex, Age, and Stent Type from 2006 to 2010 in the Re-
public of Korea
2006 (n=40653) 2007 (n=45025) 2008 (n=48963) 2009 (n=50662) 2010 (n=53589) p value
PCI
Total 37323 (91.8) 41565 (92.3) 45444 (92.8) 47405 (93.6) 50489 (94.2)
Sex <0.0001
Men 24571 (65.8) 27272 (65.6) 29632 (65.2) 31599 (66.7) 33939 (67.2)
Women 12752 (34.2) 14293 (34.4) 15812 (34.8) 15806 (33.3) 16550 (32.8)
Age, yrs <0.0001
20‒49   4837 (13.0)   5223 (12.6)   5432 (12.0)   5358 (11.3)   5566 (11.0)
50‒64 14923 (40.0) 16092 (38.7) 17135 (37.7) 17664 (37.3) 18644 (36.9)
65‒74 12393 (33.2) 14150 (34.0) 15582 (34.3) 16268 (34.3) 16863 (33.4)
≥75   5170 (13.9)   6100 (14.7)   7295 (16.1)   8115 (17.1)   9416 (18.6)
Stent type† <0.0001*
Angioplasty   4197 (11.2)   4727 (11.4)   5480 (12.1)   5693 (12.0)   6101 (12.1)
BMS   2467 (6.6)   2349 (5.7)   2569 (5.7)   2059 (4.3)   1550 (3.1)
1st-gen DES 29145 (78.1) 26751 (64.4) 24797 (54.6) 16393 (34.6)   8268 (16.4)
2nd-gen DES   4101 (11.0) 11314 (27.2) 16756 (36.9) 27470 (57.9) 33827 (67.0)
3rd-gen DES - - - -   4860 (9.6)
In-hospital mortality     544 (1.5)     615 (1.5)     707 (1.6)     748 (1.6)     909 (1.8) <0.0001
No. of hospitals  
  providing procedure
    119     125     135     140     147
CABG
Total   3330 (8.2)   3460 (7.7)   3519 (7.2)   3257 (6.4)   3100 (5.8)
Sex 0.1
Men   2295 (68.9)   2458 (71.0)   2433 (69.1)   2304 (70.7)   2208 (71.2)
Women   1035 (31.1)   1002 (29.0)   1086 (30.9)     953 (29.3)     892 (28.8)
Age, yrs <0.0001
20‒49     276 (8.3)     301 (8.7)     255 (7.2)     260 (8.0)     204 (6.6)
50‒64   1400 (42.0)   1432 (41.4)   1383 (39.3)   1266 (38.9)   1175 (37.9)
65‒74   1317 (39.5)   1363 (39.4)   1482 (42.1)   1358 (41.7)   1293 (41.7)
≥75     337 (10.1)     364 (10.5)     399 (11.3)     373 (11.5)     428 (13.8)
In-hospital mortality     130 (3.9)     104 (3.0)     111 (3.2)       90 (2.8)       96 (3.1) 0.095
No. of hospitals  
  providing procedure
      69       73       73       75       78
PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; DES, drug-eluting stent; BMS, bare-metal stents.
*First-, second-, and third-generation DES were categorized into DES. 
†Values may not add up to the total due to multiple cases.
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trends were also statistically significant (Table 4). In con-
trast, the in-hospital mortality rates for CABG decreased in 
2010 in all strata, with the exception of Tertile 1 of proce-
dure volume; statistical significance was observed only in 
<65-year-old patients and Tertile 2 of procedure volume. 
Recurrent PCI and CABG
Among 210914 patients, 194291 (92.1%) received PCI only 
(172458 received one, 19720 received two, and 2113 recei-
ved three or more PCIs), 13579 (6.4%) received CABG only 
(13556 received one and 23 received two CABGs), and 
3044 (1.4%) received both PCI and CABG (Supplementary 
Table 1, only online). 
Among the 121575 cases who received PCI between 2007 
and 2009 and who did not have histories of revasculariza-
tion during the previous 12 months, 10949 (9.0%) received 
a repeat revascularization procedure within 12 months. 
There were 10166 (8.4%) patients who received PCI and 
783 (0.6%) who received CABG as their second revascular-
ization procedure. The proportion of follow-up PCI proce-
dures was high between 7 and 10 months after the first PCI 
procedure, whereas the peak time for CABG was within 2 
months of the first PCI procedure (Supplementary Fig. 1, 
only online). 
The adjusted RR for PCI in 2010 was significantly higher 
than that in 2006 for all age and sex strata. The linear trend 
for the RR was also statistically significant (Table 2). The 
adjusted RR for CABG in 2010 was significantly lower than 
that in 2006 for age and sex strata, with the exception of the 
≥75-year-old group. 
In-hospital mortality rates from PCI and CABG 
In-hospital mortality after PCI significantly increased from 
1.5% in 2006 to 1.8% in 2010. Although in-hospital mortal-
ity due to CABG decreased during the study period, this 
change was not statistically significant in men or women 
(Table 1). 
In a generalized linear mixed-effects model, the risk of in-
hospital mortality from PCI or CABG was higher among 
women and the older-age group than among men and the 
younger-age group (Table 3); the risk of in-hospital mortali-
ty from CABG continuously decreased from 2006 to 2010, 
whereas the risk increased for PCI (p for trend=0.03). The 
risks of in-hospital mortality from PCI and CABG were sig-
nificantly higher in hospitals with low procedure volumes 
than in hospitals with the highest procedure volumes. 
Stratified analyses by age, sex, and hospital procedure 
volume indicated that the risk of in-hospital mortality was 
significantly higher in 2010 than in 2006 among women, el-
derly patients, and the highest-volume hospitals; the linear 
Fig. 1. Quarterly distribution of the number of percutaneous coronary intervention (PCI) procedures according to the type of procedure from 2006 to 2010 in 
the Republic of Korea. BMS, bare-metal stent; DES-1G, first-generation drug-eluting stent; DES-2G, second-generation drug-eluting stent; DES-3G, third-
generation drug-eluting stent.
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and 2008 in the U.S.16,18 and was 186.7 per 100000 during 
2005 in Canada.19 Compared to these results from Western 
countries, the coronary revascularization rates in our study 
were relatively low.
Trends in coronary revascularization
In our study, the increase in PCI was greater than the de-
crease in CABG, such that the overall rate of revasculariza-
tion increased. Our findings were similar to those of a previ-
DISCUSSION
We found that the rate of revascularization continuously in-
creased from 116.1 per 100000 in 2006 to 131.0 in 2010 in 
the ROK. In contrast to the increased rate of PCI (16%), the 
rate of CABG decreased (20%) during the study period. 
Previous studies have reported that the rate of revasculariza-
tion ranged from 358.0 to 556.9 per 100000 between 2001 
Table 2. Standardized Rates and Rate Ratios (95% Confidence Interval)* of Coronary Revascularization by Sex and Age
Rate per 100000/rate ratio (95% CI)
2006 2007 2008 2009 2010 p for linear trend
Total 116.1 123.5 128.9 128.6 131.0 <0.0001
1 1.06 (1.05‒1.08) 1.11 (1.10‒1.12) 1.11 (1.09‒1.12) 1.13 (1.11‒1.14)
PCI
Total 106.5 114.0 119.7 120.3 123.4 <0.0001
1 1.07 (1.05‒1.08) 1.12 (1.11‒1.14) 1.13 (1.11‒1.14) 1.16 (1.15‒1.17)
Sex
Men 143.0 152.6 159.2 163.6 169.3 <0.0001
1 1.07 (1.05‒1.08) 1.11 (1.10‒1.13) 1.14 (1.13‒1.16) 1.18 (1.17‒1.20)
Women 71.4 76.9 81.7 78.6 79.3 <0.0001
1 1.08 (1.05‒1.1) 1.14 (1.12‒1.17) 1.10 (1.08‒1.12) 1.11 (1.09‒1.13)
Age, yrs
20‒49 20.0 21.6 22.6 22.5 23.6 <0.0001
1 1.08 (1.05‒1.12) 1.13 (1.09‒1.17) 1.13 (1.09‒1.17) 1.18 (1.14‒1.22)
50‒64 203.0 209.9 212.8 209.0 209.9   0.0514
1 1.03 (1.01‒1.06) 1.05 (1.03‒1.07) 1.03 (1.01‒1.05) 1.03 (1.01‒1.06)
65‒74 406.4 445.1 474.3 484.6 493.9 <0.0001
1 1.10 (1.07‒1.12) 1.17 (1.14‒1.19) 1.19 (1.17‒1.22) 1.22 (1.19‒1.24)
≥75 228.6 251.6 280.1 288.6 309.8 <0.0001
1 1.1 (1.06‒1.14) 1.23 (1.19‒1.26) 1.26 (1.23‒1.3) 1.36 (1.32‒1.39)
CABG
Total 9.5 9.5 9.3 8.3 7.6 <0.0001
1 1.00 (0.95‒1.05) 0.97 (0.93‒1.02) 0.87 (0.83‒0.91) 0.80 (0.76‒0.84)
Sex
Men 13.4 13.8 13.1 11.9 11.0 <0.0001
1 1.03 (0.97‒1.08) 0.97 (0.92‒1.03) 0.89 (0.83‒0.94) 0.82 (0.76‒0.88)
Women 5.8 5.4 5.6 4.76 4.3 <0.0001
1 0.93 (0.85‒1.02) 0.97 (0.89‒1.06) 0.83 (0.74‒0.91) 0.75 (0.66‒0.84)
Age, yrs
20‒49 1.1 1.3 1.1 1.1 0.9   0.0197
1 1.1 (0.93‒1.26) 0.93 (0.76‒1.1) 0.96 (0.79‒1.13) 0.76 (0.58‒0.94)
50‒64 19.1 18.7 17.2 15.0 13.2   0.0009
1 0.98 (0.91‒1.05) 0.9 (0.83‒0.98) 0.79 (0.71‒0.86) 0.69 (0.62‒0.77)
65‒74 143.3 42.9 45.1 40.4 37.8   0.0001
1 0.99 (0.92‒1.07) 1.04 (0.97‒1.12) 0.93 (0.86‒1.01) 0.87 (0.80‒0.95)
≥75 15.0 15.1 15.3 13.2 14.0 0.12
1 1.01 (0.86‒1.15) 1.02 (0.88‒1.17) 0.89 (0.74‒1.03) 0.94 (0.80‒1.08)
PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; CI, confidence interval.
*Rates were standardized by a direct method to sex and age according to the distribution of the Korean population in 2008. Rate ratios and the corre-
sponding 95% CIs were estimated by Poisson regression analysis after adjusting for age and sex.
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old. There may be several reasons for the reduced rate of 
CABG. First, practice guidelines for revascularization have 
changed due to reports on the efficacy of PCI vs. CABG for 
left-main coronary disease5,6 and multi-vessel disease.7,8 
Second, patient preference or physician recommendations 
may contribute to treatment decisions and the decreased rate 
of CABG. In general, patients and physicians prefer less-in-
vasive treatments that offer equal efficacy. 
Transition of stent type
In our study, changes in the type of stent used were promi-
nent. The older-generation DES were immediately replaced 
by newer-generation models as soon as they became avail-
able, although it is unclear if the newer-generation DES 
models are truly superior. 
In addition to the enthusiasm of physicians for new medi-
cal technologies, we believe that a distorted reimbursement 
pricing policy for stents might affect the rapid changes in 
PCI stent type. The price of DES was only 20% higher than 
that of BMS; the difference between BMS and DES is about 
300 US dollars (BMS and DES cost $1500 and $1800 US 
dollars, respectively). However, in most countries, the cost 
difference between BMS and DES is greater than 1200 US 
dollars, and the price of DES is more than double that of 
BMS.22 Therefore, there might be less motivation for physi-
cians in the ROK to choose BMS rather than DES. In our 
study, more than 90% of PCI procedures involved DES. In 
addition, NHI covers only three stent implantations (two 
stents in one vessel) during the lifetime of each patient. 
Thus, due to the lower restenosis rate of DES compared to 
that of BMS, both physicians and patients might have strong 
preferences for DES. Due to the lack of clinical information 
in our study, further investigations into the suitability and re-
imbursement criteria for PCI using clinical data are neces-
sary to confirm our findings. 
Recurrent coronary revascularization
We observed a peak in the percentage of CABG within 2 
months of PCI and between 7 to 10 months for repeat PCI 
procedures. Our findings might reflect the general practice 
of routine coronary angiography after revascularization with 
PCI. If critical stenosis is confirmed with routine follow-up 
coronary angiography, repeat PCI or CABG is usually per-
formed and consequently might also increase adverse events 
after coronary revascularization. However, due to study lim-
itations, we could not distinguish repeated revascularization 
of the original lesion from revascularization due to disease 
ous study, which reported an increasing trend in the reva-
scularization rate yet divergent trends according to procedure 
type.18 Recent studies in the U.S. show that although the in-
cidence of coronary artery disease is increasing, the revascu-
larization rate, especially the rate of PCI, is decreasing or is 
unchanged after 2005.16,20,21 However, the use of the PCI pro-
cedure continuously increased during our study period, de-
spite there being no change in health care policy on the use 
of coronary revascularization procedures.
Although the PCI rate increased in all of the age and sex 
categories, the increases in the male and elderly (≥65 years 
old) groups were higher than those in the female and young 
adult (<65 years old) groups. For elderly patients, in addi-
tion to their increased risk of coronary diseases, a history of 
revascularization might also contribute to the increased rate 
of PCI. Our findings are consistent with the results from a 
U.S. study that reported an increasing trend in the rate of 
PCI between 2000 and 2006, with a greater increase among 
elderly patients.18
A decreased rate of CABG was observed in both genders 
and in all age groups, with the exception of those ≥75 years 
Table 3. The Risk of in-Hospital Mortality after Coronary Re-
vascularization
Risk ratio (95% confidence interval)*
PCI CABG
Fixed effects
Women (vs. men) 1.11 (1.04‒1.19) 1.24 (1.04‒1.49)
Age
20‒49 Reference Reference
50‒64 1.24 (1.04‒1.47) 2.20 (1.20‒3.89)
65‒74 2.75 (2.32‒3.25) 3.52 (1.93‒6.20)
≥75 6.68 (5.64‒7.90)   7.90 (4.43‒14.08)
Yr
2006 Reference Reference
2007 0.98 (0.87‒1.10) 0.77 (0.59‒1.00)
2008 1.01 (0.90‒1.13) 0.75 (0.58‒0.98)
2009 1.00 (0.90‒1.12) 0.67 (0.51‒0.89)
2010   1.11 (1.00‒1.24)* 0.73 (0.56‒0.96)
p for trend 0.03 0.01
Random effects
Procedure volume†
Tertile 1 1.56 (1.40‒1.75) 3.62 (2.72‒4.82)
Tertile 2 1.42 (1.32‒1.52) 2.31 (1.88‒2.83)
Tertile 3 Reference Reference
PCI, percutaneous coronary intervention; CABG, coronary artery bypass 
graft.
*p=0.05.
†Hospitals were divided into tertiles based on the annual number of revas-
cularization procedures.
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and repeated treatments, which might delay or prevent ap-
propriate treatment.26 Considering the decreased number of 
CABG surgeries in our study, it is also possible that high-
risk patients, such as women, the elderly, and patients with 
co-morbidities, did not receive CABG. This shift of high-
risk patients from CABG to PCI might have contributed to 
the increased rates of in-hospital mortality after PCI and the 
decreased in-hospital mortality observed with CABG.
In our study, the number of hospitals providing coronary 
revascularization continuously increased during the 5-year 
period. Given that low-volume hospitals inherently have 
worse outcomes for PCI or CABG,27-29 an increased number 
progression of other lesions or staged procedures.23-25
In-hospital mortality from coronary revascularization
Several studies in developed countries show that in-hospital 
mortality rates after coronary revascularization have either 
remained unchanged or have decreased during the last de-
cade.24 However, in our study, in-hospital mortality after PCI 
significantly increased in 2010 from 2006, with the most pro-
minent increases observed among female and elderly patients. 
Women and elderly patients are at increased risk of devel-
oping major cardiovascular events after coronary revascu-
larization due to non-specific symptoms, co-morbidities, 
Table 4. The Risk of in-Hospital Mortality after Coronary Revascularization According to Age, Sex, and Procedure Volume
        Risk ratio (95% confidence interval)
2006 2007 2008 2009 2010 p for trend
PCI
Sex
Men 1 0.95 (0.81‒1.11) 1.05 (0.91‒1.23) 1.03 (0.89‒1.20) 1.04 (0.89‒1.20) 0.35
Women 1 1.02 (0.86‒1.21) 0.96 (0.81‒1.13) 0.96 (0.81‒1.14) 1.21 (1.03‒1.42) 0.03
Age, yrs
<65 1 0.89 (0.71‒1.13) 0.96 (0.77‒1.21) 0.93 (0.74‒1.16) 1.05 (0.84‒1.31) 0.56
≥65 1 1.02 (0.89‒1.16) 1.05 (0.92‒1.20) 1.07 (0.94‒1.22) 1.21 (1.07‒1.37) 0.001
Procedure volume*/ 
  mean±SD†
Tertile 1 1 0.68 (0.48‒0.96) 0.72 (0.52‒1.02) 0.67 (0.48‒0.95) 0.78 (0.57‒1.07) 0.31
    62.9±43.08   82.6±48.18      75.2±47.63   74.3±49.44    89.4±49.21
Tertile 2 1 0.98 (0.81‒1.22) 1.13 (0.93‒1.38) 1.11 (0.91‒1.35) 1.06 (0.87‒1.29) 0.37
236.7±56.2 269.1±69.73  253.2±69.5 255.9±60.68  260.9±54.64
Tertile 3 1 1.04 (0.89‒1.21) 1.00 (0.89‒1.18) 1.02 (0.88‒1.18) 1.22 (1.06‒1.40) 0.009
    635.1±274.47 639.9±238.1      681.5±282.49      680±270.65       680±267.11
CABG
Sex
Men 1 0.84 (0.60‒1.17) 0.85 (0.61‒1.19) 0.65 (0.46‒0.94) 0.77 (0.54‒1.09) 0.06
Women 1 0.66 (0.43‒1.02) 0.60 (0.39‒0.91) 0.69 (0.45‒1.06) 0.67 (0.43‒1.03) 0.09
Age
<65 1 0.64 (0.40‒1.02) 0.72 (0.46‒1.15) 0.70 (0.43‒1.12) 0.57 (0.34‒0.97) 0.05
≥65 1 0.84 (0.61‒1.15) 0.79 (0.57‒1.08) 0.68 (0.49‒0.95) 0.85 (0.62‒1.17) 0.09
Procedure volume*/ 
  mean±SD
Tertile 1 1 1.03 (0.41‒2.61) 1.18 (0.51‒2.75) 1.06 (0.44‒2.56) 1.38 (0.58‒3.32) 0.51
  6.1±3.8 6.1±3.5      6.9±3.64   6.3±2.72    4.8±2.57
Tertile 2 1 0.52 (0.32‒0.86) 0.35 (0.20‒0.60) 0.38 (0.21‒0.66) 0.51 (0.31‒0.86) 0.002
  21.3±6.39 20.1±6.96    21.9±5.89 17.9±4.59  18.5±6.54
Tertile 3 1 0.89 (0.63‒1.24) 0.95 (0.69‒1.32) 0.81 (0.57‒1.14) 0.80 (0.56‒1.13) 0.17
    121.8±149.89   116.6±144.88 116.9±139   106.1±122.21 97.0±108
PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.
All analyses were performed separately by age and gender with the generalized linear mixed-effects model and procedure volume (tertile) as a random ef-
fect after adjusting for age (20‒49, 50‒64, 65‒74, or ≥75 years old) and/or sex. 
*Age and sex were adjusted in a generalized linear model. 
†Annual number of procedures.
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might be confounded by repeat procedures. Finally, similar 
to other epidemiological studies that use medical claims 
data,16,20,21 due to the lack of clinical information, we were 
unable to determine the causes of in-hospital mortality and 
patients characteristics such as co-morbidities, nor could we 
determine whether PCI procedures were elective, acute, or 
emergent. Acute and emergent coronary revascularizations 
usually have worse clinical outcomes compared to elective 
coronary revascularization.32,33 Our results should be care-
fully compared to those reported by other studies with elec-
tive patients. Additionally, due to the inclusion of non-coro-
nary revascularization-related deaths, in-hospital mortality 
might also be over-estimated in our study. 
In conclusion, the annual volume of coronary revascular-
ization has continuously increased in the ROK between 2006 
and 2010. In contrast to an increased rate of PCI, the rate of 
CABG decreased. A high proportion of PCI procedures in-
volved DES. Furthermore, a higher rate of in-hospital mor-
tality from coronary revascularization was observed in low-
volume hospitals. Further evaluation of outcomes and 
reimbursement policies for coronary revascularization will 
provide additional information to physicians and patients. 
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